ZA200710337B - Aspartyl protease inhibitors - Google Patents

Aspartyl protease inhibitors

Info

Publication number: ZA200710337B
Authority: ZA; South Africa
Prior art keywords: protease inhibitors; aspartyl protease; aspartyl; inhibitors; protease
Prior art date: 2005-06-14

Application number

ZA200710337A

Other languages

English (en)

Inventor

Zhu Zhaoning

Andrew W Stamford

Elizabeth M Smith

Mckittrick Brian

Huang Ying

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-14

Filing date

2007-11-28

Publication date

2008-12-31

2007-11-28 Application filed by Schering Corp filed Critical Schering Corp

2008-12-31 Publication of ZA200710337B publication Critical patent/ZA200710337B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Virology (AREA)
Epidemiology (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA200710337A 2005-06-14 2007-11-28 Aspartyl protease inhibitors ZA200710337B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US69032605P	2005-06-14	2005-06-14

Publications (1)

Publication Number	Publication Date
ZA200710337B true ZA200710337B (en)	2008-12-31

Family

ID=37074234

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200710337A ZA200710337B (en)	2005-06-14	2007-11-28	Aspartyl protease inhibitors

Country Status (17)

Country	Link
US (1)	US7759354B2 (xx)
EP (1)	EP1896477B1 (xx)
JP (1)	JP2008543840A (xx)
KR (1)	KR20080031189A (xx)
CN (1)	CN101198609A (xx)
AR (1)	AR054620A1 (xx)
AT (1)	ATE482214T1 (xx)
AU (1)	AU2006259675A1 (xx)
CA (1)	CA2610812A1 (xx)
DE (1)	DE602006017073D1 (xx)
ES (1)	ES2350854T3 (xx)
IL (1)	IL187623A0 (xx)
MX (1)	MX2007016175A (xx)
PE (1)	PE20070018A1 (xx)
TW (1)	TW200716644A (xx)
WO (1)	WO2006138192A1 (xx)
ZA (1)	ZA200710337B (xx)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7763609B2 (en)	2003-12-15	2010-07-27	Schering Corporation	Heterocyclic aspartyl protease inhibitors
US7700603B2 (en)	2003-12-15	2010-04-20	Schering Corporation	Heterocyclic aspartyl protease inhibitors
US7592348B2 (en)	2003-12-15	2009-09-22	Schering Corporation	Heterocyclic aspartyl protease inhibitors
US7759354B2 (en)	2005-06-14	2010-07-20	Schering Corporation	Bicyclic guanidine derivatives as asparyl protease inhibitors, compositions, and uses thereof
CA2609582A1 (en)	2005-06-14	2006-12-28	Schering Corporation	Aspartyl protease inhibitors
US8173642B2 (en)	2005-10-25	2012-05-08	Shionogi & Co., Ltd.	Aminodihydrothiazine derivatives
EP2644600B1 (en)	2006-06-12	2017-01-11	Merck Sharp & Dohme Corp.	Heterocyclic aspartyl protease inhibitors
JP2010512390A (ja) *	2006-12-12	2010-04-22	シェーリングコーポレイション	三環式系を含むアスパルチルプロテアーゼ阻害剤
CA2672293A1 (en)	2006-12-12	2008-06-19	Schering Corporation	Aspartyl protease inhibitors
MX2009011498A (es)	2007-04-24	2009-11-10	Shionogi & Co	Derivados de aminodihidrotiazina sustituida con un grupo ciclico.
EP2151435A4 (en)	2007-04-24	2011-09-14	Shionogi & Co	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
EP2200990A1 (en)	2007-09-06	2010-06-30	Schering Corporation	Gamma secretase modulators
WO2009061699A1 (en)	2007-11-05	2009-05-14	Schering Corporation	Gamma secretase modulators
US8426595B2 (en) *	2007-12-11	2013-04-23	Xianhai Huang	Gamma secretase modulators
EA201001532A1 (ru)	2008-04-22	2011-06-30	Шеринг Корпорейшн	Соединения фенилзамещенного 2-имино-3-метилпирролопиримидинона в качестве ингибиторов bace-1, композиции и их применение
KR101324426B1 (ko)	2008-06-13	2013-10-31	시오노기세야쿠 가부시키가이샤	β 세크레타제 저해 작용을 갖는 황 함유 복소환 유도체
US8450308B2 (en) *	2008-08-19	2013-05-28	Vitae Pharmaceuticals, Inc.	Inhibitors of beta-secretase
EP2360155A4 (en)	2008-10-22	2012-06-20	Shionogi & Co	2-AMINOPYRIDIN-4-ON AND 2-AMINOPYRIDINE DERIVATIVE WITH BACE1-HEMDERING EFFECT
JP5503663B2 (ja)	2008-11-13	2014-05-28	メルク・シャープ・アンド・ドーム・コーポレーション	ガンマセクレターゼモジュレータ
EP2379566A2 (en)	2008-12-22	2011-10-26	Schering Corporation	Gamma secretase modulators
US8759337B2 (en)	2008-12-22	2014-06-24	Merck Sharp & Dohme Corp.	Gamma secretase modulators
KR101908255B1 (ko)	2009-03-13	2018-10-15	비타이 파마슈티컬즈, 인코포레이티드	베타세크리타아제 저해제
EP2443119A1 (en)	2009-06-16	2012-04-25	Schering Corporation	Gamma secretase modulators
US20120238546A1 (en)	2009-06-16	2012-09-20	Zhaoning Zhu	Gamma secretase modulators
US20120232108A1 (en)	2009-06-16	2012-09-13	Xianhai Huang	Gamma secretase modulators
UA108363C2 (uk)	2009-10-08	2015-04-27		Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
WO2011044187A1 (en)	2009-10-08	2011-04-14	Schering Corporation	Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
WO2011044184A1 (en)	2009-10-08	2011-04-14	Schering Corporation	Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
US8569310B2 (en)	2009-10-08	2013-10-29	Merck Sharp & Dohme Corp.	Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions and their use
RU2012129168A (ru)	2009-12-11	2014-01-20	Сионоги Энд Ко. Лтд.	Производные оксазина
JP5828848B2 (ja)	2010-02-24	2015-12-09	ヴァイティーファーマシューティカルズ，インコーポレイテッド	ベータセクレターゼインヒビター
JP5766198B2 (ja)	2010-10-29	2015-08-19	塩野義製薬株式会社	縮合アミノジヒドロピリミジン誘導体
CN103261199A (zh)	2010-10-29	2013-08-21	盐野义制药株式会社	萘啶衍生物
WO2012138734A1 (en)	2011-04-07	2012-10-11	Merck Sharp & Dohme Corp.	C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
EP2694521B1 (en)	2011-04-07	2015-11-25	Merck Sharp & Dohme Corp.	Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
JPWO2012147763A1 (ja)	2011-04-26	2014-07-28	塩野義製薬株式会社	オキサジン誘導体およびそれを含有するｂａｃｅ１阻害剤
WO2013028670A1 (en)	2011-08-22	2013-02-28	Merck Sharp & Dohme Corp.	2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use
TWI557112B (zh)	2012-03-05	2016-11-11	百靈佳殷格翰國際股份有限公司	β－分泌酶抑制劑
CN106902108B (zh)	2012-03-19	2020-07-21	巴克老龄化研究所	App特异性bace抑制剂(asbi)及其用途
TW201422592A (zh)	2012-08-27	2014-06-16	Boehringer Ingelheim Int	β－分泌酶抑制劑
EP2900650A1 (en)	2012-09-28	2015-08-05	Vitae Pharmaceuticals, Inc.	Inhibitors of beta-secretase
WO2014062553A1 (en)	2012-10-17	2014-04-24	Merck Sharp & Dohme Corp.	Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
WO2014062549A1 (en)	2012-10-17	2014-04-24	Merck Sharp & Dohme Corp.	Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
JP2016501827A (ja)	2012-10-24	2016-01-21	塩野義製薬株式会社	Ｂａｃｅ１阻害作用を有するジヒドロオキサジンまたはオキサゼピン誘導体
CN104995176B (zh)	2013-02-12	2019-02-22	巴克老龄化研究所	调节bace所介导的app加工的乙内酰脲
WO2014127881A1 (de)	2013-02-25	2014-08-28	Merck Patent Gmbh	2-amino-3,4-dihydrc-chinazolin derivate und ihre verwendung als cathepsin d inhibitoren
US11766435B2 (en)	2016-02-18	2023-09-26	Merck Sharp & Dohme Llc	N3-substituted iminopyrimidinones as antimalarial agents

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3865836A (en) *	1972-12-08	1975-02-11	Janssen Pharmaceutica Nv	Bicyclic imidazoles
JPS5946518B2 (ja) *	1976-12-23	1984-11-13	第一製薬株式会社	２，２−又は３，３−ジ置換−イミダゾ〔１，２−ａ〕〔１，３〕ジアザシクロアルカン類
GB8312892D0 (en) *	1983-05-11	1983-06-15	Raychem Ltd	Electrical insulator
JPS60173546A (ja) *	1984-02-20	1985-09-06	Fuji Photo Film Co Ltd	ハロゲン化銀写真感光材料の現像処理方法
IL102764A0 (en) *	1991-08-16	1993-01-31	Merck & Co Inc	Quinazoline derivatives,and pharmaceutical compositions containing them
AU2436792A (en) *	1991-08-16	1993-03-16	Merck & Co., Inc.	Quinazoline derivatives as inhibitors of hiv reverse transcriptase
US5958920A (en) *	1994-12-02	1999-09-28	The United States Of America As Represented By The Department Of Health And Human Services	Aralkyl diazabicycloalkane derivatives for CNS disorders
EP0918771A4 (en) *	1996-07-15	2001-02-07	Bristol Myers Squibb Co	THIADIOXOBENZODIAZEPINES FOR USE AS FARNESYL PROTEIN TRANSFERASE INHIBITORS
FR2756282B1 (fr) *	1996-11-22	1998-12-31	Elf Aquitaine	Procede de synthese d'esters de l'acide mercapto-3-propionique
AU3213799A (en) *	1998-04-01	1999-10-18	Du Pont Pharmaceuticals Company	Integrin antagonists
CN1247586C (zh) *	2001-09-21	2006-03-29	赛诺菲安万特	治疗神经退化性疾病的取代的2－嘧啶基－6,7,8,9－四氢嘧啶并[1,2－a]嘧啶－4－酮及7－嘧啶基－2,3－二氢咪唑并[1,2－a]嘧啶－5(1h)酮衍生物
EP1340760A1 (en) *	2002-02-28	2003-09-03	Sanofi-Synthelabo	Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)one derivatives
EP1295885A1 (en)	2001-09-21	2003-03-26	Sanofi-Synthelabo	Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1H)one derivatives
EP1340761A1 (en) *	2002-02-28	2003-09-03	Sanofi-Synthelabo	Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)one derivatives
JP4448134B2 (ja)	2003-08-08	2010-04-07	シェーリングコーポレイション	ベンズアミド置換基を有する環状アミンｂａｓｅ−１阻害剤
AR045219A1 (es)	2003-08-08	2005-10-19	Pharmacopeia Inc	Aminas ciclicas inhibidoras de base - 1 que poseen un sustiuyente heterociclico
AU2004294933B2 (en)	2003-11-21	2011-11-17	Johns Hopkins University	Biomolecule partition motifs and uses thereof
NZ547462A (en) *	2003-12-15	2010-06-25	Schering Corp	Heterocyclic aspartyl protease inhibitors
US7763609B2 (en) *	2003-12-15	2010-07-27	Schering Corporation	Heterocyclic aspartyl protease inhibitors
US7700603B2 (en) *	2003-12-15	2010-04-20	Schering Corporation	Heterocyclic aspartyl protease inhibitors
US7592348B2 (en) *	2003-12-15	2009-09-22	Schering Corporation	Heterocyclic aspartyl protease inhibitors
JPWO2005073365A1 (ja)	2004-01-29	2007-09-13	株式会社ジャパン・ティッシュ・エンジニアリング	移植用細胞の処理方法、細胞懸濁液、移植用補綴物、および損傷部位の治療方法
DE102004007076A1 (de) *	2004-02-13	2005-08-25	Bayer Cropscience Ag	Imidazolopyrimidine
ES2321853T3 (es) *	2004-06-16	2009-06-12	Wyeth	Difenilimidazopiridina e -imidazol aminas como inhibidores de b-secretasa".
ES2332659T3 (es) *	2004-06-16	2010-02-10	Wyeth	Derivados de amino-5,5-difenilimidazolona para la inhibicion de beta-secretasa.
DE602005025363D1 (de)	2004-07-22	2011-01-27	Schering Corp	Substituierte amide als inhibitoren der beta-sekretase
AR050184A1 (es)	2004-07-28	2006-10-04	Schering Corp	Inhibidores macrociclicos de beta-secretasa
JP2008515989A (ja)	2004-10-13	2008-05-15	メルクエンドカムパニーインコーポレーテッド	アルツハイマー病を治療するためのβ−セクレターゼ阻害薬として有用なスピロピペリジン化合物
EP1802587A4 (en) *	2004-10-15	2010-02-17	Astrazeneca Ab	SUBSTITUTED AMINO BINDINGS AND THEIR APPLICATIONS
EP1848778B1 (en) *	2005-02-18	2013-04-10	North Carolina State University	De novo synthesis of bacteriochlorins
CA2609582A1 (en)	2005-06-14	2006-12-28	Schering Corporation	Aspartyl protease inhibitors
ES2436795T3 (es)	2005-06-14	2014-01-07	Merck Sharp & Dohme Corp.	Inhibidores heterocíclicos de aspartil proteasa, preparación y uso de los mismos
KR20080025079A (ko)	2005-06-14	2008-03-19	쉐링 코포레이션	아스파르틸 프로테아제 억제제
US7759354B2 (en)	2005-06-14	2010-07-20	Schering Corporation	Bicyclic guanidine derivatives as asparyl protease inhibitors, compositions, and uses thereof
DE602006018456D1 (de) *	2005-06-14	2011-01-05	Schering Corp	Herstellung und verwendung von verbindungen als aspartylproteasehemmer
WO2006138230A2 (en)	2005-06-14	2006-12-28	Schering Corporation	The preparation and use of protease inhibitors
CN101193892A (zh)	2005-06-14	2008-06-04	先灵公司	大环杂环天冬氨酰基蛋白酶抑制剂
JP2009507032A (ja) *	2005-09-02	2009-02-19	アボット・ラボラトリーズ	新規なイミダゾ系複素環
US7763606B2 (en)	2005-10-27	2010-07-27	Schering Corporation	Heterocyclic aspartyl protease inhibitors
US7560451B2 (en) *	2005-10-31	2009-07-14	Schering Corporation	Aspartyl protease inhibitors
AR059021A1 (es)	2006-01-18	2008-03-05	Schering Corp	Moduladores de receptores cannabinoides
EP2644600B1 (en)	2006-06-12	2017-01-11	Merck Sharp & Dohme Corp.	Heterocyclic aspartyl protease inhibitors
WO2008063558A2 (en)	2006-11-17	2008-05-29	Schering Corporation	Combination of an inhibitor of dna polymerase-alpha and an inhibitor of a checkpoint kinase for proliferative disorders
CA2672293A1 (en)	2006-12-12	2008-06-19	Schering Corporation	Aspartyl protease inhibitors
JP2010512390A (ja)	2006-12-12	2010-04-22	シェーリングコーポレイション	三環式系を含むアスパルチルプロテアーゼ阻害剤

2006
- 2006-06-12 US US11/451,074 patent/US7759354B2/en active Active
- 2006-06-12 ES ES06784753T patent/ES2350854T3/es active Active
- 2006-06-12 EP EP06784753A patent/EP1896477B1/en active Active
- 2006-06-12 CA CA002610812A patent/CA2610812A1/en not_active Abandoned
- 2006-06-12 AU AU2006259675A patent/AU2006259675A1/en not_active Abandoned
- 2006-06-12 KR KR1020077029729A patent/KR20080031189A/ko not_active Withdrawn
- 2006-06-12 CN CNA2006800212013A patent/CN101198609A/zh active Pending
- 2006-06-12 AT AT06784753T patent/ATE482214T1/de not_active IP Right Cessation
- 2006-06-12 MX MX2007016175A patent/MX2007016175A/es unknown
- 2006-06-12 WO PCT/US2006/022698 patent/WO2006138192A1/en not_active Ceased
- 2006-06-12 DE DE602006017073T patent/DE602006017073D1/de active Active
- 2006-06-12 AR ARP060102466A patent/AR054620A1/es not_active Application Discontinuation
- 2006-06-12 JP JP2008516963A patent/JP2008543840A/ja active Pending
- 2006-06-13 PE PE2006000661A patent/PE20070018A1/es not_active Application Discontinuation
- 2006-06-13 TW TW095121028A patent/TW200716644A/zh unknown
2007
- 2007-11-25 IL IL187623A patent/IL187623A0/en unknown
- 2007-11-28 ZA ZA200710337A patent/ZA200710337B/xx unknown

Also Published As

Publication number	Publication date
ES2350854T3 (es)	2011-01-27
PE20070018A1 (es)	2007-03-08
AR054620A1 (es)	2007-07-04
ATE482214T1 (de)	2010-10-15
HK1109151A1 (en)	2008-05-30
JP2008543840A (ja)	2008-12-04
IL187623A0 (en)	2008-03-20
EP1896477A1 (en)	2008-03-12
MX2007016175A (es)	2008-03-07
US20060281730A1 (en)	2006-12-14
AU2006259675A1 (en)	2006-12-28
US7759354B2 (en)	2010-07-20
CA2610812A1 (en)	2006-12-28
EP1896477B1 (en)	2010-09-22
TW200716644A (en)	2007-05-01
KR20080031189A (ko)	2008-04-08
CN101198609A (zh)	2008-06-11
DE602006017073D1 (en)	2010-11-04
WO2006138192A1 (en)	2006-12-28

Publication	Publication Date	Title
ZA200710386B (en)	2008-12-31	Aspartyl protease inhibitors
IL187814A0 (en)	2008-08-07	Aspartyl protease inhibitors
IL187623A0 (en)	2008-03-20	Aspartyl protease inhibitors
IL183826A0 (en)	2007-09-20	Heterocyclic aspartyl protease inhibitors
IL195592A0 (en)	2009-09-01	Heterocyclic aspartyl protease inhibitors
LT1981519T (lt)	2018-04-25	Proteazės slopinimas
ZA200905837B (en)	2012-01-25	Heterocyclic aspartyl protease inhibitors
ATE478070T1 (de)	2010-09-15	Heterozyklische aspartyl-proteasehemmer
ZA200702836B (en)	2010-06-30	Diaminoalkane aspartic protease inhibitors
IL192134A0 (en)	2009-08-03	Soft protease inhibitors and pro-soft forms thereof
EP1750696A4 (en)	2009-07-15	RETROVIRAL PROTEASE INHIBITORS RESISTING THEIR RESISTANCE
IL183850A0 (en)	2007-10-31	Hiv protease inhibitors
EP1732891A4 (en)	2009-05-06	RESISTANT PREVENTIVE INHIBITORS FOR RETROVIRAL PROTEASES
EP2064177A4 (en)	2014-08-20	PROTEASE INHIBITORS
IL177055A0 (en)	2006-12-10	Silinae compounds as cysteine protease inhibitors
GB0513841D0 (en)	2005-08-10	Cysteine protease inhibitors
EP1855672A4 (en)	2011-11-30	HIV PROTEASE INHIBITORS
ZA200804025B (en)	2009-03-25	Aspartic protease inhibitors
ZA200706305B (en)	2008-06-25	HIV protease inhibitors
GB0513839D0 (en)	2005-08-10	Cysteine protease inhibitors
GB0513840D0 (en)	2005-08-10	Cysteine protease inhibitors
HK1118808A (en)	2009-02-20	Aspartyl protease inhibitors
HK1108691A (en)	2008-05-16	Aspartyl protease inhibitors
HK1113366A (en)	2008-10-03	Aspartyl protease inhibitors
GB0507627D0 (en)	2005-05-25	Protease inhibitors